Compare EFSI & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EFSI | XGN |
|---|---|---|
| Founded | 1881 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 214.3M | 253.9M |
| IPO Year | N/A | 2019 |
| Metric | EFSI | XGN |
|---|---|---|
| Price | $39.73 | $7.13 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 6 |
| Target Price | ★ $39.50 | $13.67 |
| AVG Volume (30 Days) | 13.6K | ★ 303.7K |
| Earning Date | 10-23-2025 | 11-04-2025 |
| Dividend Yield | ★ 3.14% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.13 | N/A |
| Revenue | ★ $66,122,000.00 | $63,599,000.00 |
| Revenue This Year | N/A | $22.15 |
| Revenue Next Year | $27.28 | $15.26 |
| P/E Ratio | $18.53 | ★ N/A |
| Revenue Growth | 3.18 | ★ 14.08 |
| 52 Week Low | $28.70 | $2.67 |
| 52 Week High | $40.38 | $12.23 |
| Indicator | EFSI | XGN |
|---|---|---|
| Relative Strength Index (RSI) | 70.14 | 30.11 |
| Support Level | $37.76 | $7.01 |
| Resistance Level | $40.38 | $7.33 |
| Average True Range (ATR) | 0.76 | 0.32 |
| MACD | 0.31 | 0.07 |
| Stochastic Oscillator | 82.57 | 18.09 |
Eagle Financial Services Inc is a locally owned and managed financial institution. It offers retail and commercial banking services, including demand, savings and time deposits and consumer, mortgage, and commercial loans. It also offers telephone banking, internet banking, and mobile banking to its customers. The Company has three reportable operating segments, Community Banking, Marine Lending and Wealth Management. It generates a majority of its revenue from the Community Banking segment.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.